Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microtubule inhibition refers to the disruption of microtubule dynamics, a critical process for cell division and intracellular transport. Microtubules are cytoskeletal structures composed of α/β-tubulin heterodimers that undergo continuous polymerization (growth) and depolymerization (shortening). Agents that inhibit microtubules—often called microtubule inhibitors or antimitotic agents—interfere with these dynamics, leading to cell cycle arrest and apoptosis, particularly in rapidly dividing cells such as cancer cells.
Disruption/stabilization of tubulin polymerization/depolymerization
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microtubule Inhibition.